NewHold Investment Corp. III NHIC
Last close
10.62
2026-09-04
Market cap
—
52-week range
10.16 - 11.60
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| SG&A | $2.1M | — |
| Operating income | -$2.1M | — |
| Net income | $4.9M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | $1.2M | $55.0K |
| Total current assets | $1.3M | $382.0K |
| Total assets | $210.6M | $382.0K |
| Accounts payable | $104.0K | — |
| Total current liabilities | $1.3M | $447.0K |
| Total liabilities | $8.3M | $447.0K |
| Retained earnings | -$7.0M | -$90.0K |
| Total equity | -$7.0M | -$65.0K |
Cash flow
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Operating cash flow | -$1.0M | — |
| Investing cash flow | -$202.3M | — |
| Financing cash flow | $204.4M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-037915.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Operating cash flow
- Depreciation and amortisation
- Total current liabilities
- Total current assets
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | — | -$1.0M |
| Depreciation and amortisation | — | — |
| Total current liabilities | $447.0K | $1.3M |
| Total current assets | $382.0K | $1.3M |
Recent filings and events
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Regulation FD disclosure Item 7.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Other event Item 8.01
- Other event Item 8.01
- Material agreement signed Item 1.01
- Unregistered share sale Item 3.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $647.8M | — | — |
| IACO | Idea Acquisition Corp. | $437.1M | — | — |
| KRAQ | KRAKacquisition Corp | $431.6M | — | — |
| TACO | Berto Acquisition Corp. | $393.6M | 36.2x | — |
| ALDF | Aldel Financial II Inc. | $322.7M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $315.1M | — | — |
| FGII | FG Imperii Acquisition Corp. | $289.7M | — | — |
| SOUL | Soulpower Acquisition Corp. | $268.0M | — | — |